This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Best Practices in IBD: Differential Diagnosis

Best Practices in IBD: Differential Diagnosis


Expert Perspective

Time to Complete

30 minutes


December 19, 2017


December 19, 2018
Add to Queue

Maximum Credits

0.50 / AMA PRA Category 1 CreditTM

Accredited Provider

This educational activity is provided by the American Gastroenterological Association.

Commercial Supporter

Supported by an educational grant from Takeda Pharmaceuticals


Produced by Haymarket Medical Education (HME)

Program Description

The presentation of inflammatory bowel disease (IBD) is not specific and the differential diagnosis can therefore encompass a wide spectrum of distinct gastrointestinal disorders that can mimic and/or even coexist with IBD, which may result in delayed diagnosis and persistence of ongoing symptoms. In this activity, Dr. Gary R. Lichtenstein discusses the 2 principal manifestations of IBD—ulcerative colitis (UC) and Crohn’s disease (CD)—in the context of a patient case of a young woman with UC. The activity outlines the different pathophysiologic processes and symptoms that differentiate IBD and from functional bowel disorders such as irritable bowel syndrome, and it reviews the American Gastroenterological Association’s CD and UC “Clinical Care Pathways.”

Intended Audience

Gastroenterologists, primary care physicians, nurse practitioners, physician assistants, and other clinicians who manage patients with IBD

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Recognize the early manifestations of inflammatory bowel disease (IBD) to ensure timely diagnosis and treatment
  • Promptly refer patients to gastroenterology specialists and/or IBD centers while continuing to manage their overall health

Conflict Of Interest Disclosure Policy

In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.


Gary R. Lichtenstein, MD
Professor of Medicine
Director, Inflammatory Bowel Disease Center
Hospital of the University of Pennsylvania
Philadelphia, PA

Dr. Lichtenstein discloses that he is a consultant for Celgene Corporation and receives a salary from Salix Pharmaceuticals.

Accredited Provider and Publishing Staff Disclosures

No other individuals involved with planning and delivering the content disclosed any relevant financial relationships.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

The AGA Institute designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. AGA Institute, Haymarket Medical Education, and Takeda Pharmaceuticals do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AGA Institute, Haymarket Medical Education, or Takeda Pharmaceuticals. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


AGA Institute does not provide any warranty as to the accuracy or reliability of information presented either verbally or in writing by presenters. No responsibility is assumed by AGA Institute for any injury and/or damage to persons or property resulting from any use of such information.

If you have any questions relating to the accreditation of this activity, please contact the AGA education department at or 301-654-2055.


To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

Privacy Policy


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue